HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University.

Slides:



Advertisements
Similar presentations
The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP.
Advertisements

Syringe Access Programs & Law Enforcement: Building Alliances New York State Current April 2012.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Aligning Policing and Harm Reduction: Research to Practice Leo Beletsky, JD, MPH Northeastern University USA.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
Human rights violations against sex workers: Burden and effect on HIV Decker MR, Crago A-L, Chu SKH, Sherman SG, Seshu MS, Buthelezi K, Dhaliwal M, Beyrer.
Key Populations 18 September 2013 Béchir N’Daw, Conseiller régional en Droits de l’Homme et aux Lois, PNUD.
STIGMA AND DISCRIMINATION REDUCTION AS AN ESSENTIAL PART OF COMBINATION PREVENTION Stefan Baral, MD MPH FRCPC Center for Public Health and Human Rights,
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
WOMEN, DRUGS AND HIV Science Addressing Drugs And Health: State of the Art 20 th International AIDS Conference July 2014, Melbourne Tasnim Azim,
Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights Kevin Osborne, LINKAGES Project Director 2 March.
Police Brutality is Independently Associated with Sharing Injection Equipment among Injection Drug Users in Odessa, Ukraine Supported by the National Institute.
Enhancing Partnerships Between Law Enforcement and Civil Society Organisations in the context of Drug Use and HIV: Lessons from the field Nicholas Thomson.
ENGAGING WITH LAW ENFORCEMENT: PREVENTION, MONITORING AND RESPONSE Basha Silverman, Brandywine Counseling & Community Services.
The Global Epidemiology of HIV among Female Sex Workers: The Influence of Structural Determinants Shannon K, Strathdee SA, Goldenberg S, Duff P, Mwangi.
Operationalizing the Enabling Environment: A Binational Partnership Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Washington D.C., USA, July 2012www.aids2012.org Addressing the intersection of criminalisation, discrimination and stigma Susan Timberlake Chief,
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
Treatment of drug addiction in prisons
Harm Reduction.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
Building Trust With the Injection Drug Community Megan Hatta, RN.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
Incarceration, Reentry and Disparities in Health: What are the connections? Nicholas Freudenberg Hunter College, May 5, 2006 Presented at the Prisoner.
June 14, 2013 Harm Reduction and Drug Policy Reform 1 Harm Reduction and Drug Policy Reform in the U. S. Laura Thomas, MPH, MPP Drug Policy Alliance MIDARP's.
Washington D.C., USA, July 2012www.aids2012.org Condoms as evidence Susan Timberlake Chief, Human Rights and Law Division UNAIDS Secretariat Geneva.
Olivia Chang, MPH Research and Program Manager Pangaea Global AIDS
1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
HIV and criminalization: prevention or punishment XVIII International AIDS Conference Global Village 22 July, 2010.
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
Jennifer R. Havens, PhD, MPH Associate Professor
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
High Coverage of Most-at-Risk Populations Reduces HIV Risk: Results from Central Asia Anna Deryabina, David S. Hausner, Bibigul Aubakirova, Yana Dobronravova,
‘The War on Drugs: Failures, Impacts, and Alternatives, and the Future of Public Health’ Niamh Eastwood Release 15 November 2014.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
1 Barriers to access to sterile syringes in Canada: legal, policy and human rights issues XVI International AIDS conference Tuesday, 15 August 2006 Alana.
MODULE 3 Harm reduction advocacy
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Senior Behavioral Scientist, ICRW
Harm reduction: decriminalising drug use in Asia
Community Action on Harm Reduction (CAHR) Programme
Jack Stone, April Young, Jennifer R. Havens, Peter Vickerman
Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico Add other affiliations.
Harm Reduction at the Crossroads Drugs, drug policy, harm reduction: A reality check International AIDS Conference July 25, 2018 Amsterdam Daniel.
DRUG USE WORLDWIDE AND HIV
Modeling the impact of the Mexican drug law reform on HIV incidence among people who inject drugs (PWID) in Tijuana, Mexico. Add other affiliations for.
Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.
Towards a Conducive Legal and Structural Environment
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
The HIV Epidemic among People who Inject Drugs
Module 2: HCV transmission and risk prevention
No conflicts of interest
Human Dignity and Harm Reduction
Geneva 2019 SAFE ABORTION CARE Dr Venkatraman Chandra-Mouli.
Presentation transcript:

HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University School of Law and Bouvé College of Health Sciences, Boston, U.S), Thomas Kerr (University of British Columbia, Canada)

Overview 1. Introduction Drug-Related Laws and Policies that Influence HIV Risk Behaviors 3. Policing Practices and HIV Risks 4. Avenues for Intervention 5. Conclusions/Recommendations

The HIV risk environment Levels: –Macro (drug possession laws) –Meso (laws governing access to NSP and OST) –Micro (policing practices) Strathdee et al, Lancet 2010

Global Variations in Approaches to Responding to Drug Related Harms 14 countries: legislation allows judicial corporal punishment for drug and alcohol offences One country: has laws prohibiting OSTOne country: has laws prohibiting OST drug policy experimentation and/or depenalization30 countries: have adopted at least some form of drug policy experimentation and/or depenalization

Werb et al, BMJ Open 2013 “Despite increased investments in enforcement-based supply reduction, illegal drug prices have generally decreased while drug purity has generally increased since 1990, suggesting that efforts to control illegal drug markets through law enforcement are failing.”

Effects of criminalization on HIV risk –Disrupts access to harm reduction and other evidence-based prevention and treatment programs –Drives PWID away from preventative medical care –Reinforces stigma and discrimination –Increases risks associated with injection drug use

The HIV risk environment Levels: –Macro (drug possession laws) –Meso (laws governing access to NSP and OST) –Micro (policing practices) Strathdee et al, Lancet 2010

ACCESS TO EVIDENCE-BASED HIV PREVENTION & TREATMENT NSP in 82 countries: yet only 5% of injections covered by sterile syringesNSP in 82 countries: yet only 5% of injections covered by sterile syringes OST in 71 countries: yet only 8 per 100 PWID covered with OSTOST in 71 countries: yet only 8 per 100 PWID covered with OST Mathers et al., Lancet, 2010 Degenhardt et al., 2010; UNAIDS, 2012

Eliminating laws prohibiting OST, scaling up NSP and OST to 80% coverage in one African country could prevent 29% of new HIV infections among PWID over 5 years Strathdee et al, Lancet 2010

The HIV risk environment Levels: –Macro (drug possession laws) –Meso (laws governing access to NSP and OST) –Micro (policing practices) Strathdee et al, Lancet 2010

Direct Effects of Law Enforcement on HIV Risks Discourages PWID from carrying sterile or used syringes Discourages PWID from carrying sterile or used syringes Fuel risky injection via “hurried injecting” Fuel risky injection via “hurried injecting” Pressures PWID to inject in unsafe spaces (e.g., shooting galleries) Pressures PWID to inject in unsafe spaces (e.g., shooting galleries) Prompts risky drug and syringe storage practices that can contribute to needlestick injuries (NSI) Prompts risky drug and syringe storage practices that can contribute to needlestick injuries (NSI)

Indirect Effects of Law Enforcement on HIV Risks Displaces PWID into unsafe environments Displaces PWID into unsafe environments Discourages PWID from accessing HIV prevention programs (e.g., NSP, OST) Discourages PWID from accessing HIV prevention programs (e.g., NSP, OST) Discourages PWID from accessing emergency response Discourages PWID from accessing emergency response

Effects of law enforcement on HIV prevention National survey of NSPs in US:National survey of NSPs in US: –32% report weekly clientele harassment by police –21% report weekly confiscation of legal equipment –10% report weekly clientele arrest en route to NSP –20% report monthly police visit/interference w program –56% have no systematic way to document problems w/ police –25% participate in training w/police, but only 1 program evaluates training –17% programs report at least one client referral by police in the last year (3 programs report 6+ instances) Beletsky et al, 2011

Extra-Legal Behaviors: Police Misconduct Sexual AbuseSexual Abuse Physical AbusePhysical Abuse Soliciting BribesSoliciting Bribes Evidence PlantingEvidence Planting Precipitating forced drug withdrawalPrecipitating forced drug withdrawal

Of 33% who reported sexual favors for police, 86.2% of these were in exchange for not being arrested. Beletsky et al, 2012

A Dose-Dependent Relationship between Exposure to Police Misconduct and Syringe Sharing among PWID Hayashi et al, AIDS & Behavior, 2013

HIV infections averted by eliminating Police Beatings in Three Cities over 5 years Strathdee et al, Lancet 2010.

Police Perspective Fear of needle stick injury (NSI) and other occupational risksFear of needle stick injury (NSI) and other occupational risks Poor knowledge of infectious disease transmissionPoor knowledge of infectious disease transmission Often unaware of evidence demonstrating effectiveness of harm reduction, laws relating to syringe purchase and possession and availability and location of local harm reduction servicesOften unaware of evidence demonstrating effectiveness of harm reduction, laws relating to syringe purchase and possession and availability and location of local harm reduction services Beletsky et al, 2005

Police Education Programs (PEP) Bundling occupational safety with HIV prevention information  Occupational Safety Basic infectious disease info and Prevention tipsBasic infectious disease info and Prevention tips Glove and sharps containers distributionGlove and sharps containers distribution  Law relating to harm reduction efforts (e.g., syringe possession)  Public health rationale for harm reduction efforts  Service referral information 4. Law Enforcement and HIV Network (LEAHN) Statement of Support Davis & Beletsky, 2009

PEP Outcomes in Kyrgyzstan (n=319)  Having undergone training is independently associated with:  Intent not to confiscate syringes from PWID  Intent to refer PWID and SWs to public health programs  Institutional occupational safety procedures  Additional research needed to determine if PEPs are associated with changes in problematic police behaviors Beletsky et al, 2012

Laws and policies that criminalize drug use and possession undermine access to harm reduction and are key drivers of HIV risks among PWID. Policing practices are a pervasive barrier to the implementation and effectiveness of harm reduction programs Conclusions

Policy and legal reforms that promote public health over the criminalization of drug use and PWID are urgently needed and need rigorous evaluation There is an urgent need to re-align harm reduction and law enforcement approaches to support prevention and treatment of HIV and viral hepatitis among PWID Recommendations

 People who use drugs who have shared their stories of abuse, humiliation, violence, torture, and loss  National Institute on Drug Abuse grants R37 DA019829, R01DA and R01DA  Open Society Foundation  Nick Crofts and the Law Enforcement and HIV Network (LEAHN) Acknowledgements